Grand Challenges in Ocular Inflammatory Diseases.
作者信息
Xu Heping, Rao Narsing A
机构信息
The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.
Aier Institute of Optometry and Vision Science, Changsha, China.
出版信息
Front Ophthalmol (Lausanne). 2022 Feb 17;2:756689. doi: 10.3389/fopht.2022.756689. eCollection 2022.
Abstract
摘要
相似文献
1
Grand Challenges in Ocular Inflammatory Diseases.
Front Ophthalmol (Lausanne). 2022 Feb 17;2:756689. doi: 10.3389/fopht.2022.756689. eCollection 2022.
2
Artificial intelligence-assisted diagnosis of ocular surface diseases.
Front Cell Dev Biol. 2023 Feb 17;11:1133680. doi: 10.3389/fcell.2023.1133680. eCollection 2023.
3
Grand Challenges for Artificial Intelligence in Molecular Medicine.
Front Mol Med. 2021 Jul 22;1:734659. doi: 10.3389/fmmed.2021.734659. eCollection 2021.
4
Applying artificial intelligence in the microbiome for gastrointestinal diseases: A review.
J Gastroenterol Hepatol. 2021 Apr;36(4):832-840. doi: 10.1111/jgh.15503.
5
Common Pitfalls and Recommendations for Grand Challenges in Medical Artificial Intelligence.
Eur Urol Focus. 2021 Jul;7(4):710-712. doi: 10.1016/j.euf.2021.05.008. Epub 2021 Jun 11.
6
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.
Int J Mol Sci. 2020 Feb 1;21(3):969. doi: 10.3390/ijms21030969.
7
Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
OMICS. 2019 Nov;23(11):539-548. doi: 10.1089/omi.2019.0151. Epub 2019 Oct 25.
8
An overview of artificial intelligence in diabetic retinopathy and other ocular diseases.
Front Public Health. 2022 Oct 28;10:971943. doi: 10.3389/fpubh.2022.971943. eCollection 2022.
9
Machine learning meets omics: applications and perspectives.
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab460.
10
Advances in artificial intelligence applications for ocular surface diseases diagnosis.
Front Cell Dev Biol. 2022 Dec 20;10:1107689. doi: 10.3389/fcell.2022.1107689. eCollection 2022.
引用本文的文献
1
Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases.
Vision Res. 2023 Dec;213:108317. doi: 10.1016/j.visres.2023.108317. Epub 2023 Sep 16.
2
Taurine: a promising nutraceutic in the prevention of retinal degeneration.
Neural Regen Res. 2024 Mar;19(3):606-610. doi: 10.4103/1673-5374.380820.
3
Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature.
Front Immunol. 2023 Mar 9;14:1097456. doi: 10.3389/fimmu.2023.1097456. eCollection 2023.
4
Microemulsions as Lipid Nanosystems Loaded into Thermoresponsive In Situ Microgels for Local Ocular Delivery of Prednisolone.
Pharmaceutics. 2022 Sep 19;14(9):1975. doi: 10.3390/pharmaceutics14091975.
5
Resolution of Inflammation in Retinal Disorders: Briefly the State.
Int J Mol Sci. 2022 Apr 19;23(9):4501. doi: 10.3390/ijms23094501.
本文引用的文献
1
CD4 T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease.
Int J Mol Sci. 2021 Sep 3;22(17):9584. doi: 10.3390/ijms22179584.
2
Retinal Pigment Epithelial Cells Express Antimicrobial Peptide Lysozyme - A Novel Mechanism of Innate Immune Defense of the Blood-Retina Barrier.
Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):21. doi: 10.1167/iovs.62.7.21.
3
Uveitis: Molecular Pathogenesis and Emerging Therapies.
Front Immunol. 2021 Apr 30;12:623725. doi: 10.3389/fimmu.2021.623725. eCollection 2021.
4
Identification of an intraocular microbiota.
Cell Discov. 2021 Mar 9;7(1):13. doi: 10.1038/s41421-021-00245-6.
5
Immune Privilege: The Microbiome and Uveitis.
Front Immunol. 2021 Jan 25;11:608377. doi: 10.3389/fimmu.2020.608377. eCollection 2020.
6
Elevated gut microbiome abundance of is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly.
Gut Microbes. 2021 Jan-Dec;13(1):1-19. doi: 10.1080/19490976.2021.1880221.
7
Ocular Microbiota and Intraocular Inflammation.
Front Immunol. 2020 Dec 23;11:609765. doi: 10.3389/fimmu.2020.609765. eCollection 2020.
8
Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Front Immunol. 2020 Sep 4;11:2071. doi: 10.3389/fimmu.2020.02071. eCollection 2020.
9
Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis.
PLoS One. 2020 Aug 25;15(8):e0237995. doi: 10.1371/journal.pone.0237995. eCollection 2020.
10
New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.
ACS Pharmacol Transl Sci. 2020 Jan 20;3(1):88-106. doi: 10.1021/acsptsci.9b00075. eCollection 2020 Feb 14.
Zotero 插件